Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Amarin has a patent on this combination. Should be our first combo pill with new NCE designation as a kicker!
This is the dosing info for daily prescribed amount of IWI:
Algae oil 850mg â€
Total Omega 3 Fatty Accids 280mg â€
EPA (Eicosapentaenoic Acid) 151mg â€
DHA (Docosahexaenoic Acid) 100mg â€
Polar Lipids 90mg â€
Chlorophyll 18mg â€
You'd need to take a full bottle daily to equal Vascepa daily dose. Also you'd be taking a shitload (literally) of DHA. Although with 540 mg of Chlorophyll daily, maybe your gut could grow it's own algae? It could happen.....just saying!
I've gotten behind on some posts, could you tell me where you saw the photos of this modified Physician Cart? Thanks in advance and GLTA!
I have serious doubts about this strategy at this moment. It is difficult for me to imagine that they can generate a $25,000,000 raise and impossible to believe that it won't tank the share price. This will not be accretive IMHO. Some time spent shoring up the PPS in advance of this offering would have been highly advisable.
We will know the market reaction soon. I genuinely hope that Mac has information beyond what we investors have been provided. Otherwise I strongly question the judgement that has lead to this action. GLTA.
We seem to be settling in to the price channel we occupied before the split. Since we're still on the OTC exchange, that is really not unexpected. If change is gonna come, it'll happen on the uplist to NASDAQ.
The split gave the A-Holes a chance to screw with the stock and satisfy their GREED.
I am not an attorney so NOT an EXPERT on Patent Law. It is my understanding however that Titan can move forward with all of its plans for development and marketing while a patent dispute is undertaken. The infringement claim is initiated by the patent holder and it is the holders responsibility to prove that their patent has been infringed upon. Most of the expense falls on the patent holder....UNLESS....it is eventually demonstrated that Titan has infringed. If that is found, then Titan can be held liable for treble damages as determined by the court.
So it is incumbent upon Titan to NOT be in violation of anyone else's patents. We've seen that Mac took this possibility very seriously when one of his early moves was a full review of Titans IP. If it turns out that ISRG or anyone else challenges SPORT for patent infringement, it remains in our best interest to aggressively assert the uniqueness and validity of our technology. There is no downside for Titan, because if we can't convince the Court that SPORT does not infringe then the final result is that Titan will no longer exist!
Don't worry, be happy!
Actually this probably isn't emotional selling. This selling is done by traders and MMs who have the opportunity to manipulate pps as a result of 1 for 30 split. It won't last but it is aggravating. These maggots have no vested interest in the life or death of Titan as an entity, just in making a buck. It is the face of GREED, try to disregard it.
What?????
$1.00 Cdn is $.753 US today.
I hate to even mention it but if you look at pps for TRXC over the past several months, you can bring anything to the Robotic Surgery market and get major price movement. TITAN just needs to get Sport to market ASAP!
It is appalling to me the ease with which Market Makers can manipulate the share price of AMRN. We know they are shorting "phantom" shares but can't get regulators to take action! Disgusting.
Just for you Rafraf, by way of smarterer:
Oily stool, perhaps some skin rash. Taking 4g daily dose for 6 years? I don't remember, when did sales commence? I've taken since the beginning.
PS: Apparently doesn't help all memory issues.....
There is currently a drug listed in the FDA Orange Book. It's name is Icosapent Ethyl. It is not a naturally occurring substance. If a DS contains Icosapent Ethyl, then that constitutes selling a drug in a form that is not approved by the FDA. Isn't that enough, by definition, for the FTC to decide in Amarin's favor and preclude the sale of this illegal drug.
Thank you for your summation Bolio. As I listened to the debate, I pictured (at times just hopefully) that what you described is what was taking place among the justices. There was doubt, there was annoyance, there was irony, there was incredulity in their voices but you needed the faces to truly sense what they might have been feeling about Amarin. I don't know if we win, but it was a good fight.
I'm finishing my third glass of JW Black, listening to a retrospective on Anthony Bourdain (he is a true human being, warts and all) and I wonder if there can ever be fair resolution to this f**ked up saga with V. I've been lucky to be a V user since the beginning. It is and will continue to extend my life. Admittedly, there's no one but myself to blame but I've lost a lot with my aggressive investing in this proposition...a singularity that drew me in so completely with its inarguable rationale for success.
I've been in this stock since 2010 and owned 3000 shares when it ran to 19 and change. My employer at that time required me to get permission before I bought or sold any stocks so I only got $16.27 for 2000 of those shares back then. It really pissed me off so I bailed from the company in October of that year. I've read every post from 2010 on and I contributed content and cash to originate the EPADI. Unfortunately my investment timing has been way off....pressed the bet way too early.
I'm not feeling very positive just now, this is an anonymous message board, don't expect anyone to give a s**t. But I do hope all you new comers and old timers can hang in there long enough to pull the Brass Ring. You all deserve it for your conviction, patience, trust and persistence. I think this just might be your pot o'gold. F**k it, I'm gonna post this!
Good Night!
I agree BB, I hope they are fair minded. If they are, then Amarin is a shoo-in.
Nuke, just my opinion - but right about now, the entire Government needs a complete revision........GLTA Longs and Go AMRN!
Amarin Attorney had strong arguments and firm closing. Answered all judges queries well with statutes and case law. Opposing attorneys were definitely weaker. Several judges zoomed in on the fact that if ITC doesn't act, then Amarin has no venue. Arguments that FDA was proper venue brought criticism from judges after questions to US Attorney regarding lack of strong FDA Guidance and no "near future" plans to finalize guidance re: Dietary Supplements. (Judge was annoyed by inference in ITC briefs that FDA would have guidance soon).
One judge commented, "we have met the enemy and it is us"! It was during discussion of where does Amarin turn for ruling if dismissed today. I don't think the judges were against Amarin. US Attorney brought up issue of "pandora's box' if rule in favor of Amarin.....a serious concern.
Overall, hard to call.
Mr. North40000/Mr. OneRagMan, thanks to you both for your contributions! Can you reiterate where I may gain access to these recordings? Thanks again.
staccani, AMRN is not in NASH yet but recall this Mochida supported research from 2014:
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121528
66Mustang, thanks for voice of reason. The frustration is palpable but either Mac will perform or he won't. I'm in the prior cohort. GLTA longs!
Regarding the Teva case, one thing I find very daunting and extremely irritating is that according to the 8-K filed with the SEC regarding the settlement, Amarin has agreed to pay Teva $2,000,000.00 in recognition of savings to Amarin realized by not having to pay for continued litigation.
All I can say is WTF? I think I may file an NDA to market a Vascepa generic. I can use some extra cash after the 100+ grand that I've lost on this stock so far. Son of a bitch!
I would guess that a lot of the "Old Timers" on this board will remember Rawnoc and BRIG_88 from a few years back - huge FUD peddlers! Well I just saw on the SWING board that BRIG_88 posted in March that Rawnoc had died. I remember many of us admonished Rawnoc that maybe he should see about a script for Vascepa. Guess our collective wisdom didn't get through to him.
BB, thank you for the clarification and even more so for your perseverance in pursuing a just result for all of us shareholders. Bravo!
BB, just read this post so forgive me if already answered but who is SAS?
BB, appreciate the update and the effort you put into our cause. It seems now that all we can do is wait for the hearing.
Really, really...LIKE!
Yes that's true Nick. The best winning proposition is that AMRN goes to or above $7.00 by January 2019 expiration date and stays there. That way you sell the $4 Call for Market Price of AMRN minus $4 and you buy back the $7 Call for Market Price minus $7.
Example: AMRN at $10.00, Sell $4 Call for $6.00...Buy $7 Call for $3.00 yields $3.00 per share. Each Option represents 100 shares so $300.00 profit per option. x 10,000 Options = $3,000,000 less $500,000 cost. Not bad!
But any price above $4.50 at Option Expiration is a winner, assuming $.50 Net per Option cost. $4.50 is break even, $5.00 yields $1,000,000, $6.00 yields $2,000,000.
Jomam, it is most definitely bullish. Based on the volumes this is 99% likely a buy of the $4 Calls with an offsetting sell of the $7 Calls. If AMRN doesn't rise above $4.50 by January, the spread is a losing trade.
Thus the initiation of the trade is a Bullish proposition. That does not mean it's a sure thing!
Is there any reference to what the street might be basing that assessment on?
Hey.....maybe they plan on going for additional funding!! Ya think?
Just catching up on the message board, been prepping for a winter retreat in Delray Beach, FL. If there's about to be an AC gathering of Titan aficionados, please count me in! DRRC1949 at gmail. Go Titan.
L0tsaluck2000,
To your question re: Burn Victims and Use of EPA
This post was made (most likely last January) regarding a trial on severe burn victims....probably posted by Zumantu.
www.sciencedirect.com/science/article/pii/S026156141730002X?np=y
HC:
"PLUS another $9M from warrants from this raise = "
Just for the record, I believe this number is CD$18 million (US$14 million) from the warrants.
Right up your alley, Jesse. I'll just submit that we all need to "wait and see!" Mark that.
I had forgotten the prospectus claim referenced in this post (#62383) but the numbers gel with the expected cash influx. If you consider the private MD placement, the insider purchases and with the success of this offering, we should have funding to get us through Sept of 2018 plus a bit more.
As painful as this raise is on the back of all the recent good news and upbeat sentiment, I think I see this as a pretty clever and pragmatic initiative on Mac's part.
We all know the company is still very undervalued and that there are many upcoming announcements that can drive organic PPS growth. The market knows that as well. But on a darker note, we have to admit that there are still many risks to be overcome. So if I'm Mac, maybe I want to take advantage of the positive sentiment that exists today for both Titan AND the overall market! Unfortunately, there are a limited number of options available, so Mac has decided to bite the bullet and sponsor this new offering.
What's this mean for Titan? I guess I'm convinced there's enough enthusiasm right now to support the sale of the maximum units to be offered i.e. 30,000,000. That brings in $13,950,000 immediately.
Honeycomb recently made the point that Warrants are being executed but there are currently a limited number of less expensive ones remaining. Mac knows this as well. He also knows that just a few days ago, TMD traded at over $.60/shr. I think he believes that with upcoming events and milestones, the new warrants will be exercised quickly putting an additional $18,000,000 in Titans hands. I should also note, the broker commission will include an additional 2,100,000 warrants that should yield a further payment of $1,260,000 to Titan.
When you add up the numbers, Titan should receive a total of CD$33,210,000 in a very short time frame. This converts to nearly US$26,000,000 and goes a long way toward getting Titan to commercialization. Unfortunately, this all comes at a cost, we will need to dilute by 62,100,000 shares.
I'll leave it to others to discuss the outstanding shares issues at the end of all this. Personally, I'll feel a whole lot better with that kind of money in the bank. It just about guarantees we can get through CE and FDA, and I think Mac is counting on that as well! IMO...GLTA
I know a lot of you guys like to bust Biobill's balls, but you aren't really appreciating his arguments. Somehow you think R-IT is the key to all that is good in the world. The FDC and now the ITC have dissed the arguments put forth by Amarin to the extent that third parties may feel empowered to ride the coattails or maintain current "illegal" profiles for their DS offerings. VASCEPA is a miracle but only if it protected in the drug hierarchy and not written off as a supplement unworthy of stringent protection.
Biobill has a legitimate argument, the FDA screwed us in the past and there is little to sustain the thought that they won't do it over and over again! Our investment and our company is being assaulted daily and if the regulatory bodies are not supporting the distinction between a drug and a DS, our investment success and monetary rewards will neve be realized!!!
option-sex-press??? Schwab?? I think this is worth some consideration...
Thanks Flenderson. I know that I and many others really appreciate your feedback and I feel confident saying that few, if any, view you as "just" a cheerleader! GLTA and GO Titan!!
Thanks Mustang....we needed that clarity! Oh and thanks to you also, x1power. Please give regards to Professor Xavier and Magneto when next you return to your home planet.